Liposomal Anthracyclines for Breast Cancer: Clinical Efficacy and Safety Update

Liposomal Anthracyclines for Breast Cancer: Clinical Efficacy and Safety Update Guest Editor: Joyce O’Shaughnessy Oncologist 2003; 8(Suppl 2): 1-30 Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in breast cancer and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional).

• Liposomal Anthracyclines in Metastatic Breast Cancer: Clinical Update EXPIRED
• Liposomal Anthracyclines: Adjuvant and Neoadjuvant Therapy for Breast Cancer EXPIRED
• Cardiac Safety of Liposomal Anthracyclines EXPIRED
• Liposomal Anthracyclines and New Treatment Approaches for Breast Cancer EXPIRED